Vyne Therapeutics Inc. (VYNE)
NASDAQ · Healthcare
Vyne Therapeutics Inc. Long Term Debt 2016–2025
Vyne Therapeutics Inc. annual/quarterly long term debt history from 2019 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- Vyne Therapeutics Inc. long term debt for the quarter ending December 31, 2020 were 33.2M, a 1.37% increase year-over-year.
- Vyne Therapeutics Inc. long term debt for 2020 were 33.2M, a 1.37% increase from 2019.
- Vyne Therapeutics Inc. long term debt for 2019 were 32.7M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Vyne Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $33 |
| 2019 | $33 |
| Vyne Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2020-12-31 | $33 |
| 2019-12-31 | $33 |
Vyne Therapeutics Inc. Long Term Debt — FAQ
Vyne Therapeutics Inc. (VYNE) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VYNE's long term debt history?
The chart and table above show Vyne Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.